Clinical Trial Update: BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases. [Phase 4]

View source ↗

Summary

BLOOD-dose is a Phase 4 platform trial evaluating dose optimization in hematologic diseases, with Waldenström macroglobulinemia and multiple myeloma included; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Waldenström Macroglobulinemia

Snippet

Sponsor: Anne Louise Tølbøll Sørensen | Conditions: Waldenstrom Macroglobulinaemia, Multiple Myeloma | Phase 4 | Status: NOT_YET_RECRUITING